Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Once weekly dosing
Tirzepatide is a dual-agonist , meaning it works by targeting two hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Retatrutide is a triple-agonist , meaning it targets three hormones: GLP-1: helps regulate appetite, blood sugar, and digestion GIP: supports insulin response and reduces nausea Glucagon: affects energy use and fat metabolism Early studies show that retatrutide may be more successful than tirzepatide at managing diabetic kidney disease, as well as for weight control, while tirzepatide may be better at managing blood glucose
GHK-Cu supports those follicles structurally regardless of hormonal status, potentially improving outcomes for users on finasteride who want additional regenerative support
Oral Formulations: Traditionally injectable, new oral GLP-1 formulations are in development
US$ 25.86
US$ 26.42
US$ 26.10
US$ 29.30
US$ 23.32
US$ 24.25
US$ 20.84
